TY - JOUR
T1 - Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system
AU - Stumhofer, Jason S.
AU - Laurence, Arian
AU - Wilson, Emma H.
AU - Huang, Elaine
AU - Tato, Cristina M.
AU - Johnson, Leanne M.
AU - Villarino, Alejandro V.
AU - Huang, Qiulong
AU - Yoshimura, Akihiko
AU - Sehy, David
AU - Saris, Christiaan J.M.
AU - O'Shea, John J.
AU - Hennighausen, Lothar
AU - Ernst, Matthias
AU - Hunter, Christopher A.
PY - 2006/9
Y1 - 2006/9
N2 - Studies have focused on the events that influence the development of interleukin 17 (IL-17)-producing T helper cells (TH-17 cells) associated with autoimmunity, such as experimental autoimmune encephalitis, but relatively little is known about the cytokines that antagonize TH-17 cell effector responses. Here we show that IL-27 receptor-deficient mice chronically infected with Toxoplasma gondii developed severe neuroinflammation that was CD4+ T cell dependent and was associated with a prominent IL-17 response. In vitro, treatment of naive primary T cells with IL-27 suppressed the development TH-17 cells induced by IL-6 and transforming growth factor-β, which was dependent on the intracellular signaling molecule STAT1 but was independent of inhibition of IL-6 signaling mediated by the suppressor protein SOCS3. Thus IL-27, a potent inhibitor of TH-17 cell development, may be a useful target for treating inflammatory diseases mediated by these cells.
AB - Studies have focused on the events that influence the development of interleukin 17 (IL-17)-producing T helper cells (TH-17 cells) associated with autoimmunity, such as experimental autoimmune encephalitis, but relatively little is known about the cytokines that antagonize TH-17 cell effector responses. Here we show that IL-27 receptor-deficient mice chronically infected with Toxoplasma gondii developed severe neuroinflammation that was CD4+ T cell dependent and was associated with a prominent IL-17 response. In vitro, treatment of naive primary T cells with IL-27 suppressed the development TH-17 cells induced by IL-6 and transforming growth factor-β, which was dependent on the intracellular signaling molecule STAT1 but was independent of inhibition of IL-6 signaling mediated by the suppressor protein SOCS3. Thus IL-27, a potent inhibitor of TH-17 cell development, may be a useful target for treating inflammatory diseases mediated by these cells.
UR - http://www.scopus.com/inward/record.url?scp=33747593830&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747593830&partnerID=8YFLogxK
U2 - 10.1038/ni1376
DO - 10.1038/ni1376
M3 - Article
C2 - 16906166
AN - SCOPUS:33747593830
SN - 1529-2908
VL - 7
SP - 937
EP - 945
JO - Nature Immunology
JF - Nature Immunology
IS - 9
ER -